Healthcare
Live Price
Offline$74.46
+5.83% today
1Y Change
+917.32%
Window
Jun 20, 2025 → Jun 12, 2026
Coverage: 246 bars · Jun 20, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sol-Gel Technologies Ltd. (SLGL) is a Healthcare stock with a market cap of $210.00M and listed on NASDAQ. The stock last traded around $74.46 and up 917.3% across the available one-year price window (Jun 20, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +68.0%, EPS growth of -478.9%, a dividend yield of 0.0%. What stands out right now is revenue +68.0%, EPS -478.9%, free cash flow +102.0% with operating margin 54.4% and ROIC 43.5%. Valuation already assumes a fairly strong business story at price/sales 11.0. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines SLGL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SLGL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SLGL Max Drawdown
-35.38%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SLGL and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.